Genetic deafness testing technique consists of total blood sampling and lyophylised amplification reaction with normal and mutant primers

Backlog Engenharia Civil Outras

Genetic deafness testing technique consists of total blood sampling and lyophylised amplification reaction with normal and mutant primers

NOVELTY – The genetic deafness testing technique comprises detection of 35deIG mutation in the conexin 26 gene, using e.g. total blood samples. Also claimed is apparatus implementing the process. USE – In biology.

Main Application Field

B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.); D16 (Fermentation industry – including fermentation equipment, brewing, yeast production, production of pharmaceuticals and other chemicals by fermentation, microbiology, production of vaccines and antibodies, cell and tissue culture and genetic engineering.)

INVENTORS:

MEDRANO LEANDRO SILVA
FERES GIOVANA SAVIETTO

491_ABRIGO

Patent number: BR200304012-A

PATENT STATUS:

For information contact Inova Unicamp

FOR ADDITIONAL INFORMATION:

parcerias@inova.unicamp.br

+55 (19) 3521-5207 / 2607

This technology profile has been automatically generated.

COMPARTILHE:

TECNOLOGIAS RELACIONADAS: